"Antigens, Neoplasm" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.
Descriptor ID |
D000951
|
MeSH Number(s) |
D23.050.285
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antigens, Neoplasm".
Below are MeSH descriptors whose meaning is more specific than "Antigens, Neoplasm".
This graph shows the total number of publications written about "Antigens, Neoplasm" by people in this website by year, and whether "Antigens, Neoplasm" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 3 | 2 | 5 |
1995 | 3 | 3 | 6 |
1996 | 8 | 6 | 14 |
1997 | 10 | 4 | 14 |
1998 | 9 | 7 | 16 |
1999 | 5 | 11 | 16 |
2000 | 10 | 8 | 18 |
2001 | 6 | 18 | 24 |
2002 | 11 | 5 | 16 |
2003 | 11 | 18 | 29 |
2004 | 16 | 17 | 33 |
2005 | 18 | 19 | 37 |
2006 | 23 | 17 | 40 |
2007 | 18 | 16 | 34 |
2008 | 24 | 5 | 29 |
2009 | 13 | 9 | 22 |
2010 | 12 | 19 | 31 |
2011 | 16 | 14 | 30 |
2012 | 18 | 16 | 34 |
2013 | 16 | 12 | 28 |
2014 | 12 | 14 | 26 |
2015 | 14 | 14 | 28 |
2016 | 11 | 10 | 21 |
2017 | 13 | 12 | 25 |
2018 | 13 | 12 | 25 |
2019 | 14 | 12 | 26 |
2020 | 12 | 16 | 28 |
2021 | 11 | 9 | 20 |
2022 | 4 | 11 | 15 |
2023 | 4 | 8 | 12 |
2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antigens, Neoplasm" by people in Profiles.
-
Oncolytic adenoviruses and immunopeptidomics: a?convenient marriage. Mol Oncol. 2024 Apr; 18(4):781-784.
-
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial. Nat Med. 2024 Feb; 30(2):531-542.
-
Circulating biomarkers in familial cerebral cavernous malformation. EBioMedicine. 2024 Jan; 99:104914.
-
Autologous engineered T cell receptor therapy in advanced cancer. Hum Vaccin Immunother. 2023 Dec 15; 19(3):2290356.
-
Mechanism of stepwise electron transfer in six-transmembrane epithelial antigen of the prostate (STEAP) 1 and 2. Elife. 2023 Nov 20; 12.
-
Current perspectives on mass spectrometry-based immunopeptidomics: the computational angle to tumor antigen discovery. J Immunother Cancer. 2023 10; 11(10).
-
The interplay between neoantigens and immune cells in sarcomas treated with checkpoint inhibition. Front Immunol. 2023; 14:1226445.
-
Worth a Pound of Cure? Emerging Strategies and Challenges in Cancer Immunoprevention. Cancer Prev Res (Phila). 2023 09 01; 16(9):483-495.
-
Prognostic significance of trophoblastic cell surface antigen 2 expression and pathologic parameters in patients with ampullary adenocarcinoma. Hum Pathol. 2023 09; 139:117-125.
-
PRAME and LEF1 in Combined Deep Penetrating Nevus and Combined Blue Nevus: Utility and Pitfalls. Am J Dermatopathol. 2023 08 01; 45(8):549-556.